ÂÜÀòÂÒÂ×

Vibha Yadav, PhD, is a Principal Scientist at Ultragenyx Pharmaceutical Inc. since June 2019, with previous experience as a Scientist at REGENXBIO Inc. from January 2018 to June 2019, and as a Scientist III at Patheon part of Thermo Fisher Scientific from January 2017 to September 2017. Prior to these roles, Vibha held postdoctoral positions at Tulane Medical Center, focusing on intracellular trafficking during Influenza infection from May 2011 to April 2016, at the NIH, conducting SiRNA screening to identify host molecules related to Influenza pathogenesis from November 2009 to June 2010, and at the Max Planck Institute for Infection Biology, where SiRNA screening was employed to study Malaria and Toxoplasma from October 2006 to October 2009.